These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6648003)

  • 1. Hyperthermic regional perfusion in high-risk stage-I malignant melanomas of the extremities.
    Koops HS; Oldhoff J
    Recent Results Cancer Res; 1983; 86():223-8. PubMed ID: 6648003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
    Jönsson PE; Hafström L; Hugander A
    Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperthermic perfusion in malignant melanoma: 5-year results.
    Tonak J; Hohenberger W; Weidner F; Göhl H
    Recent Results Cancer Res; 1983; 86():229-38. PubMed ID: 6648004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic isolated regional perfusion in the treatment of extremity melanoma in children and adolescents.
    Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis WJ; van der Weele LT
    Cancer; 1989 Jan; 63(1):199-203. PubMed ID: 2910418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated hyperthermia chemotherapy perfusion for limb melanoma.
    Krementz ET; Sutherland CM; Muchmore JH
    Surg Clin North Am; 1996 Dec; 76(6):1313-30. PubMed ID: 8977553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan.
    Lejeune FJ; Deloof T; Ewalenko P; Fruhling J; Jabri M; Mathieu M; Nogaret JM; Verhest A
    Recent Results Cancer Res; 1983; 86():268-76. PubMed ID: 6648008
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanoma.
    Lejeune FJ; Mathieu M; Kenis Y
    Tumori; 1977; 63(3):289-98. PubMed ID: 898296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic perfusion with chemotherapy for melanoma of the extremities.
    Ghussen F; Krüger I; Smalley RV; Groth W
    World J Surg; 1989; 13(5):598-602. PubMed ID: 2815804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
    Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.
    Bryant PJ; Balderson GA; Mead P; Egerton WS
    World J Surg; 1995; 19(3):363-8. PubMed ID: 7638989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
    Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
    Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technique and results of hyperthermic perfusion of the extremity in melanoma patients].
    Omlor G; Bahmer F; Meessen S; Zang D; Feifel G; Zaun H
    Langenbecks Arch Chir; 1993; 378(1):21-5. PubMed ID: 8437498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.
    Hafström L; Rudenstam CM; Blomquist E; Ingvar C; Jönsson PE; Lagerlöf B; Lindholm C; Ringborg U; Westman G; Ostrup L
    J Clin Oncol; 1991 Dec; 9(12):2091-4. PubMed ID: 1960549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
    Schraffordt Koops H; Oldhoff J
    Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities.
    Martijn H; Oldhoff J; Koops HS
    J Surg Oncol; 1982 May; 20(1):9-13. PubMed ID: 7078190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regional hyperthermic perfusion has impressive effect on manifest malignant melanoma].
    Hafström L
    Lakartidningen; 1992 Sep; 89(39):3189-90. PubMed ID: 1405932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.